Market closedNon-fractional
Tenaya Therapeutics/TNYA
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Tenaya Therapeutics
Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration, and precision medicine.
Ticker
TNYA
Sector
Healthcare
Trading on
NASDAQ
Industry
Biotechnology
Headquarters
South San Francisco, United States
Employees
140
Website
www.tenayatherapeutics.com
TNYA Metrics
BasicAdvanced
$229M
Market cap
-
P/E ratio
-$1.64
EPS
2.62
Beta
-
Dividend rate
Price and volume
Market cap
$229M
Beta
2.62
Financial strength
Current ratio
6.718
Quick ratio
6.381
Long term debt to equity
4.616
Total debt to equity
7.185
Management effectiveness
Return on assets (TTM)
-38.13%
Return on equity (TTM)
-66.69%
Valuation
Price to book
1.44
Price to tangible book (TTM)
1.44
Price to free cash flow (TTM)
-2.177
Growth
Earnings per share change (TTM)
-30.20%
3-year earnings per share growth
-65.90%
What the Analysts think about TNYA
Analyst Ratings
Majority rating from 8 analysts.
TNYA Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$0
NaN%
Net income
-$32M
7.69%
Profit margin
0.00%
NaN%
TNYA Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.45
-$0.39
-$0.40
-$0.40
-
Expected
-$0.50
-$0.47
-$0.44
-$0.42
-$0.39
Surprise
-10.60%
-17.52%
-8.83%
-5.41%
-
TNYA News
AllArticlesVideos
![Tenaya Therapeutics Announces Research Leadership Updates](https://cdn.snapi.dev/images/v1/z/b/press15-2500903.jpg)
Tenaya Therapeutics Announces Research Leadership Updates
GlobeNewsWire·1 week ago
![Tenaya Therapeutics to Participate at the TD Cowen Genetic Medicines & RNA Summit](https://cdn.snapi.dev/images/v1/a/0/press7-2485610.jpg)
Tenaya Therapeutics to Participate at the TD Cowen Genetic Medicines & RNA Summit
GlobeNewsWire·2 weeks ago
![Tenaya Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update](https://cdn.snapi.dev/images/v1/w/n/press19-2430640.jpg)
Tenaya Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewsWire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Tenaya Therapeutics stock?
Tenaya Therapeutics (TNYA) has a market cap of $229M as of July 06, 2024.
What is the P/E ratio for Tenaya Therapeutics stock?
The price to earnings (P/E) ratio for Tenaya Therapeutics (TNYA) stock is 0 as of July 06, 2024.
Does Tenaya Therapeutics stock pay dividends?
No, Tenaya Therapeutics (TNYA) stock does not pay dividends to its shareholders as of July 06, 2024.
When is the next Tenaya Therapeutics dividend payment date?
Tenaya Therapeutics (TNYA) stock does not pay dividends to its shareholders.
What is the beta indicator for Tenaya Therapeutics?
Tenaya Therapeutics (TNYA) has a beta rating of 2.62. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.
![Buy or sell Tenaya Therapeutics stock](/_next/image?url=%2Fresources%2Fimages%2Fpromo_phone.png&w=256&q=75)
Buy or sell Tenaya Therapeutics stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.